drugset / Trial / NCT02216877
Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
Randomized placebo-controlled interventional trial to investigate the effect of oral magnesium supplementation on intracellular magnesium in subjects with chronic kidney disease. We hypothesize that oral magnesium supplementation will increase intracellular magnesium in subjects with chronic kidney disease as well as increase serum magnesium.
Timeline
- Start
- 2014-08
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mablet | Unknown | 360 mg | Oral |